Welcome to this week’s edition of CDP News! We like to use this space to review recent happenings in and around the Center for Deployment Psychology, while also looking ahead to upcoming events. We’re heading into the final month of the summer and getting ready for a busy fall with plenty of events, both face-to-face and virtual.
The CDP's weekly research update contains the latest news, journal articles and useful links from around the web. Some of this week's topics include:
● Clinician’s Trauma Update (June 2016)
● Posttraumatic Stress Disorder in U.S. Military Primary Care: Trajectories and Predictors of One-Year Prognosis.
Frequently, in the past couple of years a question has emerged regarding how to handle a very specific situation in mental health treatment. That situation is what to do when a patient appropriate for PTSD treatment is also taking medicinal grade prescription cannabis for other issues such as chronic pain, anxiety or insomnia. What makes this question unique from the issue of any substance use/abuse during mental health treatment is the unknown quality of this substance. For instance, if a patient states they drink 2-3 glasses of wine approximately 3 nights a week, we have a good idea of how this substance use may affect their ability to process cognitions and emotions. However, with cannabis there are many questions.
1,320 - 6,630
The estimated number of transgender active duty Service members, according to a recently published report by the RAND Corporation -- Assessing the Implications of Allowing Transgender Personnel to Serve Openly.
Welcome to this week’s edition of CDP News! We like to use this space to review recent happenings in and around the Center for Deployment Psychology, while also looking ahead to upcoming events. We had a couple of events this week to talk about and we’re laying the groundwork for even more coming up soon.